Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Limiting Remifentanil Concentration in TCI
NCT01003028Phase 4Not yet recruiting
- Sponsor
- Seoul National University Hospital
- Start
- Nov 2024
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of remifentanil in general anesthesia, sponsored by Seoul National University Hospital. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
remifentanil
03
Conditions
general anesthesia
Beyond the preview
Go deeper on NCT01003028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01003028.